Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional HER3:TRAIL fusion protein

Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional HER3:TRAIL fusion protein Ellipses Pharma granted exclusive global rights to develop and commercialise SRB22, in solid tumours LONDON and SANTIAGO DE COMPOSTELA, Spain, May 25, 2022: SunRock Biopharma S...

Related Keywords

Compostela ,Galicia ,Spain ,London ,City Of ,United Kingdom ,Sunrock Biopharma ,Rajan Jethwa ,Juan Buela ,Suzanne Wood ,Laureano Sim ,Ellipses Pharma ,Galicia Innova Tech Fund ,Ellipses Pharma Limited ,Ellipses Pharma Ltd ,